NR4A1 and pulmonary arterial hypertension: Pulmonary arterial hypertension (PAH) is a serious disease in humans and NR4A1 is downregulated in PASMCs in humans with PAH, and overexpression of NR4A1 in PASMCs blocked cell proliferation and migration [93].